A case-control study of oxidized low density lipoproteins and preeclampsia risk

References

• Williams M A, Mittendorf R. Maternal morbidity. Women & health, M B Goldman, M Hatch. Academic Press Inc, New York 2000; 172–181
   Google Scholar
• Mittendorf R, Lain K Y, Williams M A, Walker C K. Preeclampsia: A nested case-control study of risk factors and their interactions. J Reprod Med 1996; 41: 491–496
   PubMed Web of Science ®Google Scholar
• Robertson W B, Khong T Y, Brosens I, Wolf F D, Sheppard B L, Bonner J. The placental bed biopsy: review from three European centers. Am J Obstet Gynecol 1986; 155: 401–412
   PubMed Web of Science ®Google Scholar
• Roberts J M, Redman C W. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993; 341: 1447–1451
   PubMed Web of Science ®Google Scholar
• Walsh S W. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Sem Reprod Endocrinol 1998; 16: 93–104
   PubMedGoogle Scholar
• Ware-Jauregui S, Sanchez S E, Zhang C, Laraburre G, King I B, Williams M A. Plasma lipid concentrations in preeclamptic and normotensive Peruvian women. Intl J Gynecol Obstet 1999; 67: 147–155
   PubMed Web of Science ®Google Scholar
• Sanchez S E, Zhang C, Malinow M R, Ware-Jauregui S, Larrabure G, Williams M A. Plasma folate, vitamin B12 and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. Am J Epidemiol 2001; 153: 474–480
   PubMed Web of Science ®Google Scholar
• Vadachkoria S, Sanchez S E, Qiu C F, Muy-Rivera M, Malinow M R, Williams M A. Evaluation of a possible interaction between hyperhomocyst(e)inemia & elevated soluble vascular cell adhesion molecule-1 in predicting preeclampsia. Gynecol Obstet Invest 2004; 58: 133–139
   PubMed Web of Science ®Google Scholar
• Enquobahrie D A, Williams M A, Butler C L, Frederick I O, Miller R S, Luthy D A. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004; 17: 574–581
   PubMed Web of Science ®Google Scholar
• Williams M A, Farrand A, Mittendorf R, Sorensen T K, Zingheim R W, O'Reilly G C, King I B, Zebelman A M, Luthy D A. Maternal second-trimester serum tumor necrosis factor-α soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999; 149: 323–329
   PubMed Web of Science ®Google Scholar
• Qiu C, Luthy D A, Zhang C, Sorensen T K, Leisenring W M, Frederick I O, Williams M A. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of preeclampsia. Am J Hypertens 2004; 17: 154–160
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Hypertension in pregnancy. ACOG Tech Bull 1996; 219: 1–8
   Google Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1–S22
   PubMed Web of Science ®Google Scholar
• Hsieh C C, Maisonneuve P, Boyle P, Macfarlane G J, Robertson C. Analysis of quantitative data by quantiles in epidemiologic studies: Classification according to cases, noncases or all subjects. Epidemiology 1991; 2: 137–140
   PubMedGoogle Scholar
• Rothman K J, Greenland S. Modern epidemiology. 2nd ed. Lippincott-Raven Publishers, Philadelphia, PA 1998
   Google Scholar
• Branch D W, Mitchell M D, Miller E, Palinski W, Witztum J L. Preeclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet 1994; 343: 645–646
   PubMed Web of Science ®Google Scholar
• Uotila J, Solakivi T, Jaakkola O, Tuimala R, Lehtimaki T. Antibodies against copper-oxidised and mondialdehyde-modified low-density lipoproteins in preeclamptic pregnancies. Br J Obstet Gynaecol 1998; 105: 1113–1117
   PubMedGoogle Scholar
• Kurki T, Ailus K, Palosuo T, Ylikorkala O. Oxidized low-density lipoprotein, cardiolipin, and phosphatidyl serine fail to predict the risk of preeclampsia. Hyperten Preg 1996; 15: 251–256
   Web of Science ®Google Scholar
• Bowen R S, Moodley J, Dutton M F, Fickl H. Antibodies to oxidised low-density lipoproteins and cardiolipin in pre-eclampsia and eclampsia. J Obstet Gynaecol 2002; 22: 123–126
   PubMedGoogle Scholar
• Jain M, Sawhney H, Aggarwal N, Vashistha K, Majumdhar S. Auto antibodies against oxidized low density lipoprotein in severe preeclampsia. J Obstet Gynaecol Res 2004; 30: 188–192
   PubMed Web of Science ®Google Scholar
• Fialova L, Mikulikova L, Malbohan I, Benesova O, Stipek S, Zima T, Zwinger A. Antibodies against oxidized low density lipoproteins in pregnant women. Physiol Res 2002; 51: 355–361
   PubMed Web of Science ®Google Scholar
• Holvet P, Mertens A, Verhamne P, Bogaerts K, Beyens G, Verhaeghe R, Collem D, Muls F, Van de Werf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 844–848
   PubMedGoogle Scholar
• Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998; 98: 1487–1494
   PubMed Web of Science ®Google Scholar
• Fredrikson G N, Hedblad B, Berglund G, Nilsson J. Plasma oxidized LDL: A predictor for acute myocardial infaction. J Intern Med 2003; 253: 425–429
   PubMedGoogle Scholar
• Frostegard J, Wu R, Lemne C, Thulin T, Witztum J L, de Faire U. Circulating oxidized low-density lipoprotein is increased in hypertension. Clin Sci 2003; 105: 615–620
   PubMed Web of Science ®Google Scholar
• Frostegard J. Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmunity Rev 2002; 1: 233–237
   PubMedGoogle Scholar